China SXT Pharmaceuticals, Inc. (SXTC) › Net IncomeChina SXT Pharmaceuticals, Inc. (SXTC) — Net IncomeAnnual figures by fiscal year, from SEC filings.2017: $1.19M2018: $1.19M2019: $1.54M2020: -$10.29M2021: -$2.75M2022: -$5.74M2023: -$5.93M2024: -$3.10M2025: -$3.30M-$3.30M2017Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025-$3.30M-6.6%2024-$3.10M+47.8%2023-$5.93M-3.5%2022-$5.74M-108.7%2021-$2.75M+73.3%2020-$10.29M-768.4%2019$1.54M+29.6%2018$1.19M+0.2%2017$1.19M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share